Titre : Paludisme à Plasmodium vivax

Paludisme à Plasmodium vivax : Questions médicales fréquentes

Termes MeSH sélectionnés :

Methicillin-Resistant Staphylococcus aureus
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Paludisme à Plasmodium vivax : Questions médicales les plus fréquentes", "headline": "Paludisme à Plasmodium vivax : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Paludisme à Plasmodium vivax : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-05", "dateModified": "2025-02-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Paludisme à Plasmodium vivax" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Paludisme", "url": "https://questionsmedicales.fr/mesh/D008288", "about": { "@type": "MedicalCondition", "name": "Paludisme", "code": { "@type": "MedicalCode", "code": "D008288", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.920.875" } } }, "about": { "@type": "MedicalCondition", "name": "Paludisme à Plasmodium vivax", "alternateName": "Malaria, Vivax", "code": { "@type": "MedicalCode", "code": "D016780", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Nicholas M Anstey", "url": "https://questionsmedicales.fr/author/Nicholas%20M%20Anstey", "affiliation": { "@type": "Organization", "name": "Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia. Electronic address: nicholas.anstey@menzies.edu.au." } }, { "@type": "Person", "name": "Marcus V G Lacerda", "url": "https://questionsmedicales.fr/author/Marcus%20V%20G%20Lacerda", "affiliation": { "@type": "Organization", "name": "State University of Amazonas (UEA), Manaus, Amazonas, Brazil/Tropical Medicine Foundation-Dr. Heitor Vieira Dourado (FMT-HVD), Manaus, Amazonas, Brazil." } }, { "@type": "Person", "name": "Cindy S Chu", "url": "https://questionsmedicales.fr/author/Cindy%20S%20Chu", "affiliation": { "@type": "Organization", "name": "Shoklo Malaria Research Unit-Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand." } }, { "@type": "Person", "name": "Nicholas J White", "url": "https://questionsmedicales.fr/author/Nicholas%20J%20White", "affiliation": { "@type": "Organization", "name": "Shoklo Malaria Research Unit-Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand." } }, { "@type": "Person", "name": "Wuelton M Monteiro", "url": "https://questionsmedicales.fr/author/Wuelton%20M%20Monteiro", "affiliation": { "@type": "Organization", "name": "State University of Amazonas (UEA), Manaus, Amazonas, Brazil/Tropical Medicine Foundation-Dr. Heitor Vieira Dourado (FMT-HVD), Manaus, Amazonas, Brazil." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "LYZ2-SH3b as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus.", "datePublished": "2023-09-13", "url": "https://questionsmedicales.fr/article/37704938", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12866-023-03002-9" } }, { "@type": "ScholarlyArticle", "name": "Capillary electrophoretic methods for classification of methicillin-resistant Staphylococcus aureus (MRSA) clones.", "datePublished": "2022-08-31", "url": "https://questionsmedicales.fr/article/36089316", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.aca.2022.340305" } }, { "@type": "ScholarlyArticle", "name": "Relationship between mortality and molecular epidemiology of methicillin-resistant Staphylococcus aureus bacteremia.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35802589", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0271115" } }, { "@type": "ScholarlyArticle", "name": "Engineering a \"detect and destroy\" skin probiotic to combat methicillin-resistant Staphylococcus aureus.", "datePublished": "2022-12-15", "url": "https://questionsmedicales.fr/article/36520793", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0276795" } }, { "@type": "ScholarlyArticle", "name": "Proton Motive Force Inhibitors Are Detrimental to Methicillin-Resistant Staphylococcus aureus Strains.", "datePublished": "2022-08-09", "url": "https://questionsmedicales.fr/article/35943153", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1128/spectrum.02024-22" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Infection", "item": "https://questionsmedicales.fr/mesh/D007239" }, { "@type": "ListItem", "position": 3, "name": "Maladies vectorielles", "item": "https://questionsmedicales.fr/mesh/D000079426" }, { "@type": "ListItem", "position": 4, "name": "Paludisme", "item": "https://questionsmedicales.fr/mesh/D008288" }, { "@type": "ListItem", "position": 5, "name": "Paludisme à Plasmodium vivax", "item": "https://questionsmedicales.fr/mesh/D016780" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Paludisme à Plasmodium vivax - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Paludisme à Plasmodium vivax", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Paludisme à Plasmodium vivax", "description": "Comment diagnostique-t-on le paludisme à Plasmodium vivax ?\nQuels tests sont utilisés pour le paludisme ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on diagnostiquer le paludisme sans test sanguin ?\nLe diagnostic précoce est-il important ?", "url": "https://questionsmedicales.fr/mesh/D016780?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Paludisme à Plasmodium vivax", "description": "Quels sont les symptômes du paludisme à Plasmodium vivax ?\nLa fièvre est-elle constante dans le paludisme ?\nY a-t-il des symptômes spécifiques à Plasmodium vivax ?\nLes symptômes apparaissent-ils rapidement ?\nPeut-on avoir des symptômes sans infection ?", "url": "https://questionsmedicales.fr/mesh/D016780?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Paludisme à Plasmodium vivax", "description": "Comment prévenir le paludisme à Plasmodium vivax ?\nLes vaccins contre le paludisme existent-ils ?\nLes traitements préventifs sont-ils disponibles ?\nLes insecticides sont-ils efficaces contre les moustiques ?\nLes mesures d'hygiène aident-elles à prévenir le paludisme ?", "url": "https://questionsmedicales.fr/mesh/D016780?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Paludisme à Plasmodium vivax", "description": "Quel est le traitement standard pour Plasmodium vivax ?\nLa résistance aux médicaments est-elle un problème ?\nCombien de temps dure le traitement ?\nLes traitements sont-ils différents pour les enfants ?\nY a-t-il des effets secondaires au traitement ?", "url": "https://questionsmedicales.fr/mesh/D016780?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Paludisme à Plasmodium vivax", "description": "Quelles sont les complications possibles du paludisme ?\nLe paludisme peut-il être mortel ?\nComment l'anémie est-elle liée au paludisme ?\nLes complications sont-elles fréquentes ?\nLe paludisme peut-il affecter la grossesse ?", "url": "https://questionsmedicales.fr/mesh/D016780?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Paludisme à Plasmodium vivax", "description": "Quels sont les principaux facteurs de risque du paludisme ?\nLes enfants sont-ils plus à risque ?\nLes voyageurs sont-ils à risque ?\nL'immunité affecte-t-elle le risque de paludisme ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?", "url": "https://questionsmedicales.fr/mesh/D016780?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on le paludisme à Plasmodium vivax ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par un test sanguin pour détecter le parasite ou ses antigènes." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le paludisme ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de goutte épaisse et de frottis sanguin sont couramment utilisés." } }, { "@type": "Question", "name": "Les symptômes aident-ils au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes comme la fièvre et les frissons orientent vers un diagnostic de paludisme." } }, { "@type": "Question", "name": "Peut-on diagnostiquer le paludisme sans test sanguin ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, un test sanguin est essentiel pour confirmer la présence du parasite." } }, { "@type": "Question", "name": "Le diagnostic précoce est-il important ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un diagnostic précoce permet un traitement rapide et réduit les complications." } }, { "@type": "Question", "name": "Quels sont les symptômes du paludisme à Plasmodium vivax ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, frissons, maux de tête et fatigue intense." } }, { "@type": "Question", "name": "La fièvre est-elle constante dans le paludisme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, la fièvre peut être intermittente, avec des pics tous les deux jours." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques à Plasmodium vivax ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme l'anémie et la splénomégalie peuvent être plus fréquents." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils rapidement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Ils apparaissent généralement 10 à 14 jours après la piqûre du moustique infecté." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans infection ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Non, les symptômes sont généralement liés à une infection active par le parasite." } }, { "@type": "Question", "name": "Comment prévenir le paludisme à Plasmodium vivax ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation de moustiquaires imprégnées et de répulsifs est essentielle." } }, { "@type": "Question", "name": "Les vaccins contre le paludisme existent-ils ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccin spécifique pour Plasmodium vivax." } }, { "@type": "Question", "name": "Les traitements préventifs sont-ils disponibles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements préventifs peuvent être administrés aux voyageurs dans les zones à risque." } }, { "@type": "Question", "name": "Les insecticides sont-ils efficaces contre les moustiques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'utilisation d'insecticides peut réduire la population de moustiques porteurs." } }, { "@type": "Question", "name": "Les mesures d'hygiène aident-elles à prévenir le paludisme ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, maintenir un environnement propre et sans eau stagnante réduit les risques." } }, { "@type": "Question", "name": "Quel est le traitement standard pour Plasmodium vivax ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard inclut la chloroquine suivie de la primaquine pour prévenir les rechutes." } }, { "@type": "Question", "name": "La résistance aux médicaments est-elle un problème ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des cas de résistance à la chloroquine ont été signalés dans certaines régions." } }, { "@type": "Question", "name": "Combien de temps dure le traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement par chloroquine dure généralement 3 jours, suivi de 14 jours de primaquine." } }, { "@type": "Question", "name": "Les traitements sont-ils différents pour les enfants ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les doses sont ajustées en fonction du poids et de l'âge de l'enfant." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires au traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires comme des nausées et des maux de tête peuvent survenir." } }, { "@type": "Question", "name": "Quelles sont les complications possibles du paludisme ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'anémie sévère, l'insuffisance rénale et le coma." } }, { "@type": "Question", "name": "Le paludisme peut-il être mortel ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans traitement approprié, le paludisme peut entraîner la mort." } }, { "@type": "Question", "name": "Comment l'anémie est-elle liée au paludisme ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "L'anémie résulte de la destruction des globules rouges par le parasite." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont plus fréquentes chez les personnes non traitées ou immunodéprimées." } }, { "@type": "Question", "name": "Le paludisme peut-il affecter la grossesse ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut entraîner des complications graves pour la mère et le fœtus." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque du paludisme ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent vivre dans une zone endémique et ne pas utiliser de protection." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants ont un risque accru de développer des formes sévères de paludisme." } }, { "@type": "Question", "name": "Les voyageurs sont-ils à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyageurs vers des zones endémiques doivent prendre des précautions." } }, { "@type": "Question", "name": "L'immunité affecte-t-elle le risque de paludisme ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant déjà été infectées peuvent avoir une immunité partielle." } }, { "@type": "Question", "name": "Les personnes immunodéprimées sont-elles plus vulnérables ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles courent un risque accru de complications graves liées au paludisme." } } ] } ] }

Sources (10000 au total)

LYZ2-SH3b as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus.

Enzybiotics are promising alternatives to conventional antibiotics for drug-resistant infections. Exolysins, as a class of enzybiotics, show antibacterial effects against methicillin-resistant Staphyl... This study designed a chimeric exolysin by fusing the Cell-binding domain (SH3b) from Lysostaphin with the lytic domain (LYZ2) from the gp61 enzyme. Subsequently, LYZ2-SH3b was cloned and expressed in... Analysis of bioinformatics showed that LYZ2-SH3b was stable, soluble, and non-allergenic. Protein purification was performed with a 0.8 mg/ml yield for LYZ2-SH3b. The plate lysis assay results indicat... The study suggests that phage endolysins, such as LYZ2-SH3b, may represent a promising new approach to treating MRSA infections, particularly in cases where antibiotic resistance is a concern. But fur...

Pediatric Utilization of Methicillin-resistant Staphylococcus aureus Nasal Swabs for Antimicrobial Stewardship.

Methicillin-resistant Staphylococcus aureus (MRSA) can cause serious infections and empiric treatment regimens in children frequently include an anti-MRSA antibiotic. Studies in adults have demonstrat... This was a single-site, retrospective cohort study of pediatric patients admitted with a suspected infectious diagnosis who had an MNS performed during their hospitalization between June 1, 2018 and N... This study identified 172 patients who met the inclusion criteria. Eleven (6.4%) nasal swabs were positive for MRSA and 10 (5.8%) microbiological cultures from suspected sources of infection were iden... MNS has a high NPV and low PPV in children. MNS can be utilized as an antimicrobial stewardship tool to guide the safe de-escalation of anti-MRSA antibiotics in children....

Methicillin-Resistant Staphylococcus aureus Pneumatoceles in a Neonate With Sotos Syndrome : A Case Report.

Necrotizing pneumonia caused by methicillin-resistant Staphylococcus aureus can lead to the formation of pneumatoceles in the lungs. Standard treatment guidelines are not available due to the rarity o... Baby H. required prolonged respiratory support and supplemental oxygen to maintain appropriate oxygen saturation parameters for infants more than 34 weeks' gestation corrected. He was found to have mu... Baby H. was a former 32.2-week gestation male infant diagnosed with pneumonia caused by necrotizing methicillin-resistant Staphylococcus aureus leading to pneumatocele formation in both lungs.... Baby H. was managed with aggressive antibiotic therapy and then was conservatively managed until he received a tracheostomy tube on day of life (DOL) 75 to prepare for discharge home.... Baby H. was discharged from the neonatal intensive care unit (NICU) on DOL 113 with a tracheostomy tube for prolonged mechanical ventilatory support and a gastrostomy tube for nutrition. Numerous foll... While methicillin-resistant Staphylococcus aureus pneumatoceles are uncommon in the NICU setting, it is important for neonatal care providers to be aware of the causes and treatment choices currently ...

Biofilm-producing ability of methicillin-resistant Staphylococcus aureus clinically isolated in China.

Staphylococcus aureus, a commensal bacterium, colonizes the skin and mucous membranes of approximately 30% of the human population. Apart from conventional resistance mechanisms, one of the pathogenic... Analyzing non-repetitive clinical isolates of MRSA collected from seven provinces and cities in China between 2014 and 2020, it was observed that 53.2% of the MRSA isolates exhibited varying degrees o... MRSA strains with biofilm production capability warrant increased vigilance....

Markers of epidemiological success of methicillin-resistant Staphylococcus aureus isolates in European populations.

Methicillin-resistant Staphylococcus aureus (MRSA) infections impose a considerable burden on health systems, yet there is remarkable variation in the global incidence and epidemiology of MRSA. The MA... Operational definitions of success were defined in consortium meetings to compose a balanced strain collection of successful and sporadic MRSA isolates. Isolates were subjected to antimicrobial suscep... Heterogeneity of MRSA isolate collections across countries hampered the use of a unified operational definition of success; therefore, country-specific approaches were used to establish the MACOTRA st... Our results are the strongest yet to associate MRSA antibiotic resistance profiles and antibiotic usage with the incidence of infection and successful clonal spread, which varied by country. Harmonize...